Literature DB >> 12965881

Reproductive factors in Hodgkin's disease in women.

Sally L Glaser1, Christina A Clarke, Rebecca A Nugent, Cynthia B Stearns, Ronald F Dorfman.   

Abstract

Reproductive factors have been suggested to have an impact on the development of Hodgkin's disease (HD) in women. In the San Francisco Bay Area, the authors conducted a population-based case-control study addressing the effects of reproductive experience and hormone use on HD risk. Cases were 370 women with HD diagnosed at ages 19-79 years between July 1988 and December 1994. Controls were 450 community women found through random digit dialing. Among the 312 cases and 325 controls interviewed, HD risk was related to parity versus nulliparity but only among never nursers (odds ratio (OR)=2.2, 95% confidence interval (CI): 1.0, 5.0). Risk was marginally related to having uterine fibroids (OR=0.6, 95% CI: 0.5, 1.0) and long-term versus short-term hormone use (OR=0.7, 95% CI: 0.4, 1.0) and was significantly related to recurrent miscarriage (OR=2.8, 95% CI: 1.1, 7.4). Among women aged 35-54 years, for whom the sex difference in incidence is largest, nursing decreased risk; among never nursers, a parity of 1 lowered risk and higher parity increased risk; long-term hormone use lowered risk; and recurrent miscarriage increased risk. Among women under age 35 years, endometriosis lowered HD risk; the lack of significant findings for most other variables may reflect selection bias in controls. Among older women, no significant associations were observed, although hormone use appeared to be protective. These data suggest that steroid hormones may affect HD development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12965881     DOI: 10.1093/aje/kwg198

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  12 in total

1.  Effect of parity on fetal and maternal microchimerism: interaction of grafts within a host?

Authors:  Hilary S Gammill; Katherine A Guthrie; Tessa M Aydelotte; Kristina M Adams Waldorf; J Lee Nelson
Journal:  Blood       Date:  2010-07-13       Impact factor: 22.113

2.  Lymphoid malignancies in U.S. Asians: incidence rate differences by birthplace and acculturation.

Authors:  Christina A Clarke; Sally L Glaser; Scarlett L Gomez; Sophia S Wang; Theresa H Keegan; Juan Yang; Ellen T Chang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-04-14       Impact factor: 4.254

3.  Recent changes in breast cancer incidence and risk factor prevalence in San Francisco Bay area and California women: 1988 to 2004.

Authors:  Theresa H M Keegan; Ellen T Chang; Esther M John; Pamela L Horn-Ross; Margaret R Wrensch; Sally L Glaser; Christina A Clarke
Journal:  Breast Cancer Res       Date:  2007-09-25       Impact factor: 6.466

4.  Different time trends by gender for the incidence of Hodgkin's lymphoma among young adults in the USA: a birth cohort phenomenon.

Authors:  Cairong Zhu; Bryan A Bassig; Kunchong Shi; Peter Boyle; Huan Guo; Tongzhang Zheng
Journal:  Cancer Causes Control       Date:  2014-05-31       Impact factor: 2.506

5.  Availability and accuracy of medical record information on language usage of cancer patients from a multi-ethnic population.

Authors:  Laura A McClure; Sally L Glaser; Sarah J Shema; Laura Allen; Charles Quesenberry; Esther M John; Scarlett L Gomez
Journal:  J Immigr Minor Health       Date:  2010-08

6.  Racial/ethnic variation in EBV-positive classical Hodgkin lymphoma in California populations.

Authors:  Sally L Glaser; Margaret L Gulley; Christina A Clarke; Theresa H Keegan; Ellen T Chang; Sarah J Shema; Fiona E Craig; Joseph A Digiuseppe; Ronald F Dorfman; Risa B Mann; Hoda Anton-Culver; Richard F Ambinder
Journal:  Int J Cancer       Date:  2008-10-01       Impact factor: 7.396

7.  Reproductive factors, exogenous hormone use and risk of lymphoid neoplasms among women in the National Institutes of Health-AARP Diet and Health Study Cohort.

Authors:  Lindsay M Morton; Sophia S Wang; Douglas A Richesson; Arthur Schatzkin; Albert R Hollenbeck; James V Lacey
Journal:  Int J Cancer       Date:  2009-06-01       Impact factor: 7.396

8.  Hodgkin lymphoma incidence in ethnic enclaves in California.

Authors:  Sally L Glaser; Ellen T Chang; Christina A Clarke; Theresa H M Keegan; Juan Yang; Scarlett Lin Gomez
Journal:  Leuk Lymphoma       Date:  2015-06-18

9.  Polymorphisms in Th1/Th2 cytokine genes, hormone replacement therapy, and risk of non-Hodgkin lymphoma.

Authors:  Gongjian Zhu; Dongsheng Pan; Tongzhang Zheng; Qing Lan; Xuezhong Chen; Yingtai Chen; Christopher Kim; Xiaofeng Bi; Theodore Holford; Peter Boyle; Brian Leaderer; Stephen J Chanock; Nathaniel Rothman; Yawei Zhang
Journal:  Front Oncol       Date:  2011-07-28       Impact factor: 6.244

10.  Hodgkin lymphoma incidence in California Hispanics: influence of nativity and tumor Epstein-Barr virus.

Authors:  S L Glaser; C A Clarke; E T Chang; J Yang; S L Gomez; T H Keegan
Journal:  Cancer Causes Control       Date:  2014-04-11       Impact factor: 2.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.